Christine A Poon insider trades
Open-market stock purchases and sales by Christine A Poon, Director at Prudential Financial Inc, from SEC Form 4 filings since Jan 1, 2010.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +147%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 10, 2026 | PRU Prudential Financial Inc | Bought (not open market) | $19.1K |
| Sep 10, 2026 | PRU Prudential Financial Inc | Bought (not open market) | $5.8K |
| Sep 10, 2026 | PRU Prudential Financial Inc | Bought (not open market) | $2.5K |
| Jun 11, 2026 | PRU Prudential Financial Inc | Bought (not open market) | $18.9K |
| Jun 11, 2026 | PRU Prudential Financial Inc | Bought (not open market) | $5.8K |
| Jun 11, 2026 | PRU Prudential Financial Inc | Bought (not open market) | $2.4K |
| May 27, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| May 21, 2026 | NBIX Neurocrine Biosciences Inc | Bought (not open market) | — |
| May 12, 2026 | PRU Prudential Financial Inc | Sold (not open market) | $181K |
| May 12, 2026 | PRU Prudential Financial Inc | Bought (not open market) | — |
| May 12, 2026 | PRU Prudential Financial Inc | Bought (not open market) | — |
| Mar 12, 2026 | PRU Prudential Financial Inc | Bought (not open market) | $18.6K |
| Mar 12, 2026 | PRU Prudential Financial Inc | Bought (not open market) | $5.6K |
| Mar 12, 2026 | PRU Prudential Financial Inc | Bought (not open market) | $2.4K |
| Jan 2, 2026 | REGN Regeneron Pharmaceuticals, Inc | Bought (not open market) | — |
| Jan 2, 2026 | REGN Regeneron Pharmaceuticals, Inc | Bought (not open market) | — |
| Dec 11, 2025 | PRU Prudential Financial Inc | Bought (not open market) | $17.7K |
| Dec 11, 2025 | PRU Prudential Financial Inc | Bought (not open market) | $5.4K |
| Dec 11, 2025 | PRU Prudential Financial Inc | Bought (not open market) | $2.2K |
| Oct 30, 2025 | REGN Regeneron Pharmaceuticals, Inc | Bought (not open market) | — |
| Oct 29, 2025 | REGN Regeneron Pharmaceuticals, Inc | Sold | $467K |
| Oct 29, 2025 | REGN Regeneron Pharmaceuticals, Inc | Sold | $255K |
| Oct 29, 2025 | REGN Regeneron Pharmaceuticals, Inc | Sold | $424K |
| Oct 29, 2025 | REGN Regeneron Pharmaceuticals, Inc | Sold | $1.8M |
| Oct 29, 2025 | REGN Regeneron Pharmaceuticals, Inc | Sold | $1.3M |
Companies traded
- PRU Prudential Financial Inc: other filings, last Sep 10, 2026
- NBIX Neurocrine Biosciences Inc: other filings, last May 27, 2026
- REGN Regeneron Pharmaceuticals, Inc: 2 buys, 39 sales, last Jan 2, 2026
- SHW Sherwin Williams Co: other filings, last Apr 4, 2025
- DBTX Decibel Therapeutics, Inc: other filings, last Feb 11, 2021